Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoWhat’s more...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 11 hours agoThe Stock Advisor service has more than quadrupled the return...since 2002*. *Stock Advisor returns...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 3 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 3 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 3 days agoDespite a 19% decline in total company revenues to $14.9 billion, primarily due to the reduced...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 2 days agoNow, investors are zeroing...projected for the first half of 2024. Moderna stock analysts project...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 4 days agoThe Stock Advisor service has more than quadrupled the return...since 2002*. *Stock Advisor returns...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 3 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks· 5 days agoBioNTech’s top line currently comprises sales of its mRNA-based COVID-19 vaccine, Comirnaty, developed in partnership with Pfizer ...